{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of L-Ornithine-L-Aspartate in a Rat Model of Hind Limb Ischemia"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "randomly assigned to three groups"
      },
      "Participants": {
        "score": 2,
        "evidence": "male Sprague Dawley rats (n=21)"
      },
      "Intervention": {
        "score": 2,
        "evidence": "randomly assigned to three groups: control (normal saline), sorbitol, and LOLA"
      },
      "Objective": {
        "score": 1,
        "evidence": "This study investigates the potential of L-Ornithine-L-Aspartate (LOLA) to enhance angiogenesis and perfusion in a rat model of hind limb ischemia (HLI)."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "Perfusion imaging was performed on PODs 7 and 14"
      },
      "Randomisation_Allocation": {
        "score": 1,
        "evidence": "Randomisation was stratified by body weight"
      },
      "Blinding": {
        "score": 1,
        "evidence": "outcome assessors were blinded to group allocation"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "male Sprague Dawley rats (n=21)"
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "mean difference = 13.77, 95% CI 1.23 to 26.31; p < 0.05"
      },
      "Harms": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Trial registration: Not applicable."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified."
      }
    },
    "total_score": 15,
    "max_score": 25
  },
  "model": "gpt-4o"
}